4//SEC Filing
Dicerna Pharmaceuticals Inc 4
Accession 0001209191-14-012283
CIK 0001399529operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 3:28 PM ET
Size
15.2 KB
Accession
0001209191-14-012283
Insider Transaction Report
Form 4
MADDEN DAVID
Director
Transactions
- Exercise/Conversion
Common Stock
2014-01-24$3.42/sh+112,511$384,788→ 112,511 total - Purchase
Common Stock
2014-01-29$15.00/sh+7,500$112,500→ 120,011 total - Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-24−1,200→ 0 totalExercise: $3.42Exp: 2019-06-02→ Common Stock (1,200 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-24−1,311→ 0 totalExercise: $3.42Exp: 2020-10-14→ Common Stock (1,311 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2014-01-24−110,000→ 0 totalExercise: $3.42Exp: 2023-09-24→ Common Stock (110,000 underlying) - Award
Employee Stock Option (right to buy)
2013-09-24+110,000→ 110,000 totalExercise: $3.42Exp: 2023-09-24→ Common Stock (110,000 underlying)
Footnotes (3)
- [F1]25% vests after the 1 year anniversary of vesting start date of 6/2/09 and the remaining 75% vests at 1/36 per month thereafter.
- [F2]25% vests after the 1 year anniversary of vesting start date of 8/5/11 and the remaining 75% vests at 1/36 per month thereafter.
- [F3]Vests 1/36 monthly on last day of each month with a vesting start date of 07/30/2013.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001399529
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 3:28 PM ET
- Size
- 15.2 KB